Stay updated on FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma

Sign up to get notified when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.
Latest website image capture
Clouds background image

Latest updates to the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:52:28.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page footer; Removed notices for funding lapse (Revision: v3.4.1) and related operating status messages. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:26:26.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A government funding status notice was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:54:35.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a glossary toggle and new QC status indicators (Results Submitted, Last Update Submitted that Met QC Criteria) with revision v3.4.0; entries for No Results Posted, No FEAR Act data, and the previous revision v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:54:02.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4, indicating a minor update without changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:53:17.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The study Locations section has been expanded and reorganized to include a detailed list of Chinese sites (Anhui, Beijing Municipality, Guangdong, Guangzhou, Hainan, Heilongjiang, Henan, Hubei, Hunan, Jiangsu, Jiangxi, Jilin, Liaoning, Nanchang, Neimenggu, Shanghai Municipality, Shanxi, Shijiazhuang, Sichuan, Tianjin Municipality, Xian). The revision label was updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure item appears removed.
    Difference
    2%
    Check dated 2025-12-23T21:33:19.000Z thumbnail image

Stay in the know with updates to FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma

Enter your email address, and we'll notify you when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.